RxDoctor Payments Data

Courtney Dunavant

Surgical · Austin, TXNPI 1760563233

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $367,121 of the $388,789 with a category attached, or 94.4%. Galderma Laboratories, L.p. accounts for 79.0% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2021 at $114,334 and has fallen 72.9% since, to $30,965 in 2025. Among surgical clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$388,789in general payments, 2019–2025

Across 413 payments — averaging $941.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Galderma Laboratories, L.p.$307K
  • AbbVie$82K
  • Revance Therapeutics, Inc.$72
  • Merz North America, Inc.$57

What the payments were for

  • Speaking & faculty fees$367,12194%
  • Travel & lodging$18,2025%
  • Food & beverage$3,4661%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Galderma Laboratories, L.p.261$306,995
AbbVie(2 entities)148$81,665
Revance Therapeutics, Inc.2$72
Merz North America, Inc.2$57

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$388,789 in reported general payments places this provider in the 95th percentile of 804 surgical providers in Texas.

See all surgical providers in Texas →

Other surgical in Austin

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →